Faster Response to IV vs Intranasal Ketamine in Depression

In one of the first studies to compare efficacy of IV and intranasal ketamine, results suggest a faster response for the IV form -- although, at the end, overall response was similar.

Related Keywords

Boston ,Massachusetts ,United States ,Mclean Hospital ,Canada ,Toronto ,Ontario ,American ,Canadian ,Rogers Mcintyre ,Balwinder Singh ,Robert Meisner ,American Psychiatric Association ,Mclean Ketamine Service ,Alkermes ,Drug Administration ,Boehringer Ingelheim ,Harvard Medical School ,Atai Life Sciences ,Newbridge Pharmaceuticals ,Pfizer ,University Of Toronto ,Mayo Clinic Depression Center ,Division Of Psychiatric Neurotherapeutics ,Bausch Health ,Lundbeck ,Novo Nordisk ,Mayo Clinic ,American Psychiatric ,Mayo Clinic Depression ,Item Quick Inventory ,Depressive Symptomatology ,Erlos Danlos Syndrome ,Canadian Institutes ,Global Alliance ,National Natural Science Foundation ,Neumora Therapeutics ,Mitsubishi Tanabe ,Atai Life ,Depression ,Intravenous Iv ,Intravenous ,Tv ,Major Depression ,Major Depressive Disorder ,Nipolar Depression ,Remission ,Affective Disorders ,Mood Disorder ,Psychology ,Bipolar Depression ,Bipolar Disorder Depression ,Bipolar Disorder ,Bipolar Mania ,Manic Depression ,Ipolar Affective Disorder ,Epression Manic ,Chronic Disease ,Chronic Illness ,Adverse Effects ,Side Effects ,Us Food And Drug Admin ,